These findings suggest that GCK may reshape the immune microenvironment of the central nervous system by maintaining the dynamic equilibrium of microglial proliferation, migration, and apoptosis; however, it is crucial to validate these effects in differentiated neuronal models to better understand their relevance in AD pathology (Fig. 2). This evidence concerns the gene GCK and Alzheimer disease.